G

CytoMed Therapeutics Limited
D

GDTC

2.01000
USD
-0.29
(-12.61%)
مغلق
حجم التداول
626
الربح لكل سهم
0
العائد الربحي
-
P/E
-8
حجم السوق
23,584,761
أصول ذات صلة المقالات

العنوان: CytoMed Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.